Merck & Co Inc (NYSE:MRK)
$ 130.38 2.81 (2.2%) Market Cap: 330.23 Bil Enterprise Value: 358.83 Bil PE Ratio: 144.87 PB Ratio: 8.18 GF Score: 85/100

Merck & Co Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 12:30AM GMT
Release Date Price: $85.75 (+0.47%)
Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

Good afternoon, everybody. I'm Chris Schott from JPMorgan. I'm very pleased to be hosting Merck today. From the company, we have Ken Frazier, Chairman and CEO; as well as Roger Perlmutter, President of Merck Research Labs.

First of all, Happy New Year, and thanks for joining us.

Kenneth C. Frazier
Merck & Co., Inc. - Chairman, President & CEO

Happy New Year to you, Chris, and thanks for having us.

Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

Yes, we're going to be doing a fireside chat format. And like prior years, we're not going to be doing a breakout afterwards, so we'll just do the chat and then break from there.

Questions & Answers

Christopher Thomas Schott
JP Morgan Chase & Co, Research Division - Senior Analyst

So maybe Ken to open up and just help us set the stage for the conversation. Can you talk a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot